Physician profile
Julia C Espel
NPI 1134456742
$4,704.71
in general payments reported to CMS, 2019-2025
22 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $247 · 2021: $607 · 2022: $548 · 2023: $843 · 2024: $518 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,068.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,631.95 | 2019-2025 | Nucala, Trelegy Ellipta |
| Electromed, INC. | $525.36 | 2019-2024 | Smartvest |
| Astrazeneca Pharmaceuticals LP | $391.46 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $358.44 | 2019-2023 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Insmed, INC. | $297.43 | 2020-2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $222.32 | 2019-2025 | |
| Genzyme Corporation | $188.28 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $185.10 | 2019-2024 | |
| Grifols USA, LLC | $127.60 | 2021-2024 | Prolastin-C Liquid |
| Philips North America LLC | $123.72 | 2019-2025 | Vest Therapy Und |
| Genentech USA, INC. | $119.37 | 2019-2023 | Xolair |
| Abbvie INC. | $98.65 | 2020-2025 | |
| Inogen, INC. | $75.31 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| Regeneron Healthcare Solutions, INC. | $63.31 | 2021-2022 | |
| Mylan Specialty L.P. | $61.01 | 2019-2024 | Yupelri |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $60.58 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $45.25 | 2019 | |
| Amgen INC. | $40.42 | 2022-2023 | Tezspire |
| Advanced Respiratory, INC | $29.07 | 2021 | |
| Baxter Healthcare | $27.08 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Vapotherm INC | $17.01 | 2021 | |
| Circassia INC. | $15.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Espel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.